首页|急性上呼吸道感染合并发热患者治疗中连花清瘟的应用效果分析

急性上呼吸道感染合并发热患者治疗中连花清瘟的应用效果分析

扫码查看
目的 分析急性上呼吸道感染合并发热患者治疗中连花清瘟的应用效果。方法 选取2023年1—10月在本院就诊的90例急性上呼吸道感染合并发热患者作为研究对象,并根据治疗方案的不同将其分为对照组和观察组,每组45例。其中,对照组采用常规治疗,观察组在对照组的基础上采用连花清瘟治疗。对比两组患者的临床症状缓解时间、炎症因子水平、治疗效果和不良反应发生情况。结果 观察组患者的各项临床症状缓解时间用时更短(P<0。05);治疗后观察组患者的TNF-α、IL-6、hs-CRP指标均低于对照组(P<0。05);观察组患者的治疗有效率更高(P<0。05);且两组患者的不良反应发生率差异无统计学意义(P>0。05)。结论 急性上呼吸道感染合并发热患者应用连花清瘟治疗,能够在短时间内改善临床症状和炎症因子水平,取得较为理想的治疗效果,且具有较高的用药安全性。
Application Effect Analysis of Lianhua Qingwen in Treatment of Patients with Acute Upper Respiratory Tract Infection and Fever
Objective To analyze the effect of Lianhua qingwen in treatment of patients with acute upper respiratory tract infection complicated with fever. Methods The paper chose 90 patients with acute upper respiratory tract infection complicated with fever in our hospital from January to October 2023,and divided them into two groups according to different treatment schemes,treated with routine treatment scheme(45 cases in the control group) and routine+Lianhua Qingwen treatment scheme(45 cases in the observation group). Clinical symptom relief time,inflammatory factor levels,treatment effect,and incidence of adverse reactions were compared between two groups. Results The observation group had shorter time for relief of various clinical symptoms (P<0.05). After treatment,levels of TNF-α,IL-6,and hs CRP in the observation group were lower than the control group (P<0.05). Treatment effective rate of the observation group was higher,(P<0.05),there was no significant difference in incidence of adverse reactions between two groups (P>0.05). Conclusion Lianhua Qingwen treatment can improve clinical symptoms and inflammatory factor levels of patients with acute upper respiratory tract infection and fever in a short period of time,achieve ideal curative effect and high medication safety.

Acute upper respiratory tract infectionFeverLianhua qingwenApplication effect

冯芸

展开 >

呼和浩特市第一医院感染性疾病科,内蒙古 呼和浩特 010030

急性上呼吸道感染 发热 连花清瘟 应用效果

2024

智慧健康

智慧健康

ISSN:
年,卷(期):2024.10(29)